Suppr超能文献

过敏状况与脑肿瘤风险。

Allergic conditions and brain tumor risk.

作者信息

Wigertz Annette, Lönn Stefan, Schwartzbaum Judith, Hall Per, Auvinen Anssi, Christensen Helle Collatz, Johansen Christoffer, Klaeboe Lars, Salminen Tiina, Schoemaker Minouk J, Swerdlow Anthony J, Tynes Tore, Feychting Maria

机构信息

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

出版信息

Am J Epidemiol. 2007 Oct 15;166(8):941-50. doi: 10.1093/aje/kwm203. Epub 2007 Jul 23.

Abstract

An inverse association between allergic conditions and glioma risk has been reported previously. In this large population-based case-control study, the authors identified cases diagnosed with glioma or meningioma in Denmark, Norway, Finland, Sweden, and southeast England between 2000 and 2004. Detailed information on self-reported physician-diagnosed allergic conditions was collected from 1,527 glioma cases, 1,210 meningioma cases, and 3,309 randomly selected controls. Logistic regression showed an odds ratio of 0.70 (95% confidence interval: 0.61, 0.80) for glioma associated with a diagnosis of any of asthma, hay fever, eczema, or other type of allergy. The risk estimates for glioma were around 0.65 for each allergic condition (asthma, eczema, hay fever, and food allergy), and the 95% confidence intervals were equally consistent, at around 0.55, 0.80. The reduced risks of glioma related to eczema, hay fever, and allergy overall, but not asthma, were confined to current rather than past conditions. Meningioma risk was not associated with allergic conditions, except for eczema (odds ratio = 0.74, 95% confidence interval: 0.60, 0.91). Our results show a reduced risk for glioma associated primarily with current allergic conditions. If this is etiologic, it has implications for the understanding of how allergic conditions might reduce the tumor risk.

摘要

先前已有报道称过敏状况与胶质瘤风险之间存在负相关。在这项基于大规模人群的病例对照研究中,作者确定了2000年至2004年间在丹麦、挪威、芬兰、瑞典和英格兰东南部被诊断为患有胶质瘤或脑膜瘤的病例。从1527例胶质瘤病例、1210例脑膜瘤病例和3309例随机选择的对照中收集了关于自我报告的医生诊断过敏状况的详细信息。逻辑回归显示,被诊断患有哮喘、花粉症、湿疹或其他类型过敏中的任何一种与胶质瘤相关的优势比为0.70(95%置信区间:0.61, 0.80)。对于每种过敏状况(哮喘、湿疹、花粉症和食物过敏),胶质瘤的风险估计约为0.65,95%置信区间同样一致,约为0.55, 0.80。与胶质瘤风险降低相关的湿疹、花粉症和总体过敏,但不包括哮喘,仅限于当前而非过去的状况。脑膜瘤风险与过敏状况无关,除了湿疹(优势比 = 0.74,95%置信区间:0.60, 0.91)。我们的结果显示,胶质瘤风险降低主要与当前过敏状况相关。如果这是病因性的,那么对于理解过敏状况如何降低肿瘤风险具有重要意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验